Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 Vincristine 3 Vinblastine 3 Rituximab 3 Prednisone 3 Nivolumab 3 Gemcitabine 3 Dacarbazine 3 Bleomycin 3 pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Cisplatin 2 Brentuximab Vedotin 2 Blood Specimen Collection 2 treosulfan 1 tislelizumab 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡